Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US5911983

Title:Gene therapy for Gaucher disease using retroviral vectors
Inventors:Barranger, John A.; Gibsonia, PA, USA
Robbins, Paul; Pittsburgh, PA, USA
Bahnson, Alfred B.; Pittsburgh, PA, USA
Summary:Described herein are therapeutic genetic methods for the treatment of Gaucher disease with retroviral vectors. The invention relates to the use of retroviral vectors which express a DNA molecule encoding the glucocerebrosidase gene, and which are applied to a process by which autologous human hematopoietic progenitor cells, namely, human CD34+ cells, are transduced with these retroviral vectors. Specific therapeutic methods are provided for transplanting the transduced cells into a Gaucher disease patient in order to provide therapeutically effective levels of glucocerebrosidase activity.
Abstract:The present invention relates to gene therapy for Gaucher disease using retroviral vectors which express the glucocerebrosidase gene. Methods are provided for transduction of autologous hematopoietic stem cells (e.g., human CD34+ cells) with these vectors and for transplantation of the transduced cells into a Gaucher disease patient to provide therapeutically effective levels of glucocerebrosidase activity. The invention also provides for retroviral vectors that express the glucocerebrosidase gene, and for human hematopoietic cells that contain the retroviral vector.
US Patent Website:Click Here for Full Text of Patent
Title Number:US5911983
Application Number:US1995000466597
Date Filed:06/06/1995
Date Published:15/06/1999
Assignee:University of Pittsburgh, Pittsburgh, PA, USA


 
Copyright © 2007 The Institute for Cellular Medicine  8/12/2020